Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ

about

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ

Item

http://www.wikidata.org/entity/Q58695163

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@en

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@nl

type

Item

label

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@en

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@nl

prefLabel

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@en

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@nl

P1476

Successful use of ofatumumab i ...... mutation in protein kinase C δ

@en

P2093

Despina Eleftheriou

http://www.w3.org/2001/XMLSchema#string

Muthana Al-Obaidi

http://www.w3.org/2001/XMLSchema#string

Paul Brogan

http://www.w3.org/2001/XMLSchema#string

Sabina Muhammad

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.

Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial.

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial

Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis

Phosphorylation of protein kinase Cdelta on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide

B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ.

Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans

P2888

s12969-018-0278-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1186/S12969-018-0278-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Neil J. Sebire

Linda Lei

Iek Cheng

P577

2018-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107253579

http://www.w3.org/2001/XMLSchema#string

P698

30257684

http://www.w3.org/2001/XMLSchema#string

P921

Infections

thrombocytopenia

P932

6158832

http://www.w3.org/2001/XMLSchema#string